900196586	900196586	CD	B-NP	O
|	|	NN	I-NP	O
STOHC	STOHC	NN	I-NP	O
|	|	NN	I-NP	O
30612183	30612183	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5753063	5753063	CD	B-NP	O
|	|	CC	I-NP	O
10/28/2005	10/28/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
chf	chf	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/17/2005	1/17/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/11/2005	10/11/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
VOGLUND	VOGLUND	NNP	B-NP	O
,	,	,	O	O
GERRY	GERRY	NNP	B-NP	O
G.	G.	NNP	I-NP	O
203-05-33-5	203-05-33-5	CD	I-NP	O
Lu	Lu	NNP	I-NP	O
Eu	Eu	NNP	I-NP	O
Bi	Bi	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
1/1/05	1/1/05	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DENARDO	DENARDO	NNP	B-NP	O
,	,	,	O	O
JULIAN	JULIAN	NNP	B-NP	O
JUDE	JUDE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
VITAMIN	VITAMIN	NNP	I-NP	O
C	C	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASCORBIC	ASCORBIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
CALCITRIOL	CALCITRIOL	NNP	I-NP	O
0.25	0.25	CD	I-NP	O
MCG	MCG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
VITAMIN	VITAMIN	NN	I-NP	O
B12	B12	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CYANOCOBALAMIN	CYANOCOBALAMIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
PROPINE	PROPINE	NN	I-NP	O
0.1	0.1	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
DIPIVEFRIN	DIPIVEFRIN	NN	I-NP	O
0.1	0.1	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
DROP	DROP	NN	I-NP	O
OU	OU	NN	I-NP	O
BID	BID	NN	I-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
FOLIC	FOLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
ROBITUSSIN	ROBITUSSIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
GUAIFENESIN	GUAIFENESIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	B-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
sore	sore	RB	B-ADVP	O
throat	throat	IN	B-PP	O
ATROVENT	ATROVENT	NN	B-NP	O
INHALER	INHALER	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
IPRATROPIUM	IPRATROPIUM	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
112	112	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ZAROXOLYN	ZAROXOLYN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOLAZONE	METOLAZONE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-INTJ	O
give	give	VB	B-VP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
before	before	IN	B-PP	O
Torsemide	Torsemide	NNP	B-NP	O
OXYCODONE	OXYCODONE	NNP	I-NP	O
5-10	5-10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/5/05	1/5/05	CD	B-NP	O
by	by	IN	B-PP	O
HAWKS	HAWKS	NNP	B-NP	O
,	,	,	O	O
CHADWICK	CHADWICK	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.PH	M.PH	NNP	B-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
OXYCODONE	OXYCODONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
48319587	48319587	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Codeine	Codeine	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
VITAMIN	VITAMIN	NN	I-NP	O
B6	B6	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PYRIDOXINE	PYRIDOXINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ALDACTONE	ALDACTONE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/30/05	10/30/05	CD	B-NP	O
by	by	IN	B-PP	O
KARMA	KARMA	NNP	B-NP	O
,	,	,	O	O
CONRAD	CONRAD	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.PH	M.PH	NNP	B-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
32377312	32377312	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/18/05	10/18/05	CD	B-NP	O
by	by	IN	B-PP	O
RUDDY	RUDDY	NNP	B-NP	O
,	,	,	O	O
GILBERT	GILBERT	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.PH	M.PH	NNP	B-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
K-DUR	K-DUR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
70910019	70910019	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/18/05	10/18/05	CD	B-NP	O
by	by	IN	B-PP	O
YEDDO	YEDDO	NNP	B-NP	O
,	,	,	O	O
MARCELINO	MARCELINO	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.PH	M.PH	NNP	B-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
05654525	05654525	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/5/05	1/5/05	CD	B-NP	O
by	by	IN	B-PP	O
ROULSTON	ROULSTON	NNP	B-NP	O
,	,	,	O	O
NOE	NOE	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.PH	M.PH	NNP	B-NP	O
.	.	.	O	O

SERIOUS	SERIOUS	JJ	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ZOCOR	ZOCOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

NEURONTIN	NEURONTIN	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
300	300	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
K-DUR	K-DUR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
LHC	LHC	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/18/05	10/18/05	CD	B-NP	O
by	by	IN	B-PP	O
ANTRONICA	ANTRONICA	NNP	B-NP	O
,	,	,	O	O
MARC	MARC	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.PH	M.PH	NNP	B-NP	O
.	.	.	O	O

SERIOUS	SERIOUS	JJ	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
aware	aware	JJ	I-NP	O
BACTRIM	BACTRIM	NN	I-NP	O
SS	SS	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
TRIMETHOPRIM	TRIMETHOPRIM	NN	I-NP	O
/	/	SYM	I-NP	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NN	I-NP	O
SI	SI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
TORSEMIDE	TORSEMIDE	NN	I-NP	O
150	150	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
TRUSOPT	TRUSOPT	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
DORZOLAMIDE	DORZOLAMIDE	NN	B-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
DROP	DROP	NNP	I-NP	O
OU	OU	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
FLONASE	FLONASE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FLUTICASONE	FLUTICASONE	NNP	I-NP	O
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
INH	INH	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
XALATAN	XALATAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LATANOPROST	LATANOPROST	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
DROP	DROP	NNP	I-NP	O
OU	OU	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
MICONAZOLE	MICONAZOLE	NN	I-NP	O
NITRATE	NITRATE	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
POWDER	POWDER	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
apply	apply	RB	B-ADVP	O
under	under	IN	B-PP	O
breast	breast	NN	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
groin	groin	NN	B-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

thanks	thank	NNS	B-NP	O
.	.	.	O	O

ALBUTEROL	ALBUTEROL	NN	B-NP	O
AND	AND	CC	I-NP	O
IPRATROPIUM	IPRATROPIUM	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
MG	MG	NN	I-NP	O
INH	INH	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
FEMARA	FEMARA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LETROZOLE	LETROZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
L	L	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LENTE	LENTE	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
HUMAN	HUMAN	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
70	70	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
54	54	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NN	I-NP	O
with	with	IN	B-PP	O
dinner	dinner	NN	B-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
QAM	QAM	NN	I-NP	I-protein
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Bergsma	Bergsma	NNP	B-NP	O
call	call	VBP	B-VP	O
friday	friday	JJ	B-NP	O
morning	morning	NN	I-NP	O
to	to	TO	B-PP	O
,	,	,	O	O
Brussel	Brussel	NNP	B-NP	O
call	call	VBP	B-VP	O
Friday	Friday	NNP	B-NP	O
am	am	NN	I-NP	O
to	to	TO	B-PP	O
schedule	schedule	NN	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
NITROFURANTOIN	NITROFURANTOIN	NNP	B-NP	O
MACROCRYSTAL	MACROCRYSTAL	NNP	I-NP	O
,	,	,	O	O
Codeine	Codeine	NNP	B-NP	O
,	,	,	O	O
CIPROFLOXACIN	CIPROFLOXACIN	NNP	B-NP	O
,	,	,	O	O
OFLOXACIN	OFLOXACIN	NNP	B-NP	O
,	,	,	O	O
NITROFURANTOIN	NITROFURANTOIN	NNP	B-NP	O
,	,	,	O	O
DIPYRIDAMOLE	DIPYRIDAMOLE	NNP	B-NP	O
,	,	,	O	O
PENICILLIN	PENICILLIN	NNP	B-NP	O
V	V	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chf	chf	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
chf	chf	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dm	dm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
syncope	syncope	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
syncope	syncope	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
iron	iron	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
iron	iron	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pernicious	pernicious	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
treated	treat	VBN	I-NP	O
GIB	GIB	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
unspecified	unspecified	JJ	I-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
I.	I.	LS	B-NP	O
INFORMATION	INFORMATION	NN	I-NP	O
**	**	SYM	I-NP	O
Presentation	Presentation	NN	I-NP	O
:	:	:	O	O
73	73	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
PMH	PMH	NN	B-NP	O
of	of	IN	B-PP	O
AS	AS	NN	B-NP	O
AVA	AVA	NN	I-NP	O
0.74	0.74	CD	I-NP	O
cm2	cm2	NN	I-NP	O
,	,	,	O	O
median	median	JJ	B-NP	O
gradient	gradient	NN	I-NP	O
36	36	CD	I-NP	O
mmHg	mmHg	NN	I-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
exacs	exac	NNS	I-NP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
clinically	clinically	RB	B-ADVP	O
in	in	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
worsening	worsen	VBG	B-VP	O
AS	AS	JJ	B-NP	O
AVA	AVA	NN	I-NP	O
074	074	CD	I-NP	O
cm2	cm2	NN	I-NP	O
,	,	,	O	O
LVEF	LVEF	NN	B-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
CKD	CKD	NN	B-NP	O
Final	Final	JJ	I-NP	O
Diagnosis	Diagnosis	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
Treatment	Treatment	NN	I-NP	O
and	and	CC	I-NP	O
Response	Response	NN	I-NP	O
:	:	:	O	O
Note	Note	VB	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
difficult	difficult	JJ	I-ADJP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
her	her	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
status	status	NN	I-NP	O
-	-	HYPH	B-NP	O
JVP	JVP	NN	I-NP	B-protein
difficult	difficult	JJ	I-NP	O
2/2	2/2	CD	I-NP	O
girth	girth	NN	I-NP	O
of	of	IN	B-PP	O
neck	neck	NN	B-NP	O
,	,	,	O	O
often	often	RB	B-ADVP	O
incontinent	incontinent	JJ	B-ADJP	O
so	so	RB	B-ADJP	O
I/O	I/O	NN	I-ADJP	O
inaccurate	inaccurate	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
leg	leg	NN	I-NP	O
edema	edema	NN	I-NP	O
2/2	2/2	CD	I-NP	O
PVD	PVD	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
adjusted	adjust	VBD	B-VP	O
diuretic	diuretic	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
primarily	primarily	RB	B-ADVP	O
by	by	IN	B-PP	O
how	how	WRB	B-ADVP	O
she	she	PRP	B-NP	O
symptomatically	symptomatically	RB	B-ADVP	O
felt	feel	VBD	B-VP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Torsemide	Torsemide	NN	B-NP	O
200	200	CD	I-NP	O
iv	iv	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Zaroxylyn	Zaroxylyn	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
po	po	NN	I-NP	I-protein
bid	bid	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
30	30	CD	B-NP	I-protein
min	min	NN	I-NP	I-protein
before	before	IN	B-PP	I-protein
torsemide	torsemide	NN	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
Aldactone	Aldactone	NN	B-NP	O
25	25	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
1.6	1.6	CD	B-NP	O
to	to	TO	B-PP	O
2.2	2.2	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
though	though	IN	B-SBAR	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
is	be	VBZ	B-VP	O
1.6-2	1.6-2	CD	B-NP	O
.0	.0	CD	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
used	use	VBD	B-VP	O
this	this	DT	B-NP	O
,	,	,	O	O
along	along	IN	B-ADVP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
symptomatic	symptomatic	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
and	and	CC	I-NP	O
return	return	NN	I-NP	O
of	of	IN	B-PP	O
weight	weight	NN	B-NP	O
to	to	TO	B-PP	O
dry	dry	JJ	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
114.5	114.5	CD	B-NP	O
kg	kg	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
establish	establish	VB	I-VP	O
euvolemia	euvolemia	NN	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
final	final	JJ	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
stay	stay	NN	B-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
150	150	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
zaroxlyn	zaroxlyn	NN	B-NP	O
5	5	CD	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aldactone	aldactone	NN	B-NP	O
25	25	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
stable	stable	JJ	B-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

Relevant	Relevant	NNP	B-NP	O
Data	Data	NNP	I-NP	O
:	:	:	O	O
Weight	Weight	NN	B-NP	O
at	at	IN	B-PP	O
d/c	d/c	NN	B-NP	O
114.5	114.5	CD	I-NP	O
;	;	:	O	O
VS	VS	NN	B-NP	O
@	@	NN	I-NP	O
d/c	d/c	NN	I-NP	O
98.0	98.0	CD	I-NP	O
,	,	,	I-NP	O
81	81	CD	I-NP	O
,	,	,	I-NP	O
106/60	106/60	CD	I-NP	O
,	,	,	I-NP	O
20	20	CD	I-NP	O
,	,	,	I-NP	O
93	93	CD	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
;	;	:	O	O
rales	rale	NNS	B-NP	O
at	at	IN	B-PP	O
left	left	JJ	B-NP	O
base	base	NN	I-NP	O
Brief	Brief	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
See	See	VB	B-VP	O
above	above	IN	B-PP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
related	related	JJ	I-NP	O
info	info	NN	I-NP	O
In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
pan-sensitive	pan-sensitive	JJ	B-NP	O
E-coli	E-coli	NNP	I-NP	O
UTI	UTI	NN	I-NP	O
-	-	HYPH	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
x	x	CC	O	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
her	her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
cough	cough	NN	I-NP	O
worsened	worsen	VBD	B-VP	O
in	in	IN	B-PP	O
severity	severity	NN	B-NP	O
and	and	CC	O	O
became	become	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
productive	productive	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
never	never	RB	B-ADVP	O
mounted	mount	VBD	B-VP	O
a	a	DT	B-NP	O
WBC	WBC	NNP	I-NP	B-cell_type
,	,	,	O	O
never	never	RB	B-ADVP	O
was	be	VBD	B-VP	O
febrile	febrile	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
CXR	CXR	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

Felt	Felt	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
2/2	2/2	CD	B-NP	O
underlying	underlie	VBG	I-NP	O
COPD	COPD	NN	I-NP	B-protein
-	-	HYPH	O	O
improved	improve	VBN	B-VP	O
significantly	significantly	RB	B-ADVP	O
with	with	IN	B-PP	O
nebulizer	nebulizer	NN	B-NP	O
tx	tx	NN	I-NP	O
and	and	CC	O	O
Robitussen	Robitussen	NNP	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
02	02	CD	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
ambulatory	ambulatory	JJ	I-NP	O
02	02	CD	I-NP	O
sat	sat	NN	I-NP	O
was	be	VBD	B-VP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
nocturnal	nocturnal	JJ	I-NP	B-protein
O2	O2	NN	I-NP	I-protein
sats	sat	NNS	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
done	do	VBN	B-VP	O
by	by	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
were	be	VBD	B-VP	O
89-93	89-93	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
not	not	RB	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
02	02	CD	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
may	may	MD	B-VP	O
want	want	VB	I-VP	O
to	to	TO	I-VP	O
consider	consider	VB	I-VP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

II	II	CD	B-NP	O
Action	Action	NN	I-NP	O
Plan	Plan	NN	I-NP	O
:	:	:	O	O
**	**	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
told	tell	VBD	B-VP	O
to	to	TO	I-VP	O
contact	contact	VB	I-VP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
and	and	CC	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
first	first	JJ	I-NP	O
thing	thing	NN	I-NP	O
in	in	IN	B-PP	O
am	am	NN	B-NP	O
after	after	IN	B-PP	O
discharged	discharged	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
decision	decision	NN	I-NP	O
made	make	VBN	B-VP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
after	after	IN	B-PP	O
5	5	CD	B-NP	O
pm	pm	NN	I-NP	O
so	so	IN	B-SBAR	O
appts	appt	NNS	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
scheduled	schedule	VBN	I-VP	O
-RRB-	-RRB-	NNP	B-NP	O
**	**	SYM	O	O
Medication	Medication	NNP	B-NP	O
Changes	Changes	NNP	I-NP	O
:	:	:	O	O
All	All	DT	B-NP	O
diuretics	diuretic	NNS	I-NP	O
and	and	CC	I-NP	O
DM	DM	NN	I-NP	O
medications	medication	NNS	I-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
Bactrim	Bactrim	NNP	I-NP	O
course	course	NN	I-NP	O
completed	complete	VBD	B-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
d/c	d/c	VB	I-VP	O
New	New	NNP	B-NP	O
med	me	VBD	B-VP	O
=	=	SYM	B-NP	O
robitussen	robitussen	NN	I-NP	O
Patient	Patient	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
her	her	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
status	status	NN	I-NP	O
b/c	b/c	NN	I-NP	O
JVP	JVP	NN	I-NP	O
diff	diff	NN	I-NP	O
assess	assess	NN	I-NP	O
2/2	2/2	CD	I-NP	O
morbid	morbid	NN	I-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
incontinent	incontinent	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
weights	weight	NNS	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
unreliable	unreliable	JJ	B-ADJP	O
;	;	:	O	O
today	today	NN	B-NP	O
weight	weight	NN	I-NP	O
up	up	RB	B-ADVP	O
1	1	CD	B-NP	O
lb	lb	NN	I-NP	O
,	,	,	O	O
I/O	I/O	NN	B-NP	B-protein
-1	-1	CD	I-NP	I-protein
L	L	NN	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
increasing	increase	VBG	I-VP	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
yesterday	yesterday	NN	B-NP	I-protein
am	am	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
;	;	:	O	O
neurologically	neurologically	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
;	;	:	O	O
Sig	Sig	NNP	B-NP	B-protein
Daily	Daily	NNP	I-NP	O
events	event	NNS	I-NP	O
:	:	:	O	O
new	new	JJ	B-NP	O
cough	cough	NN	I-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-VP	O
WBC	WBC	NNP	B-NP	O
Sig	Sig	NNP	I-NP	O
procedures/Tests	procedures/Test	NNS	I-NP	O
:	:	:	O	O
CXR	CXR	NN	B-NP	B-protein
pending	pende	VBG	B-VP	O
r/o	r/o	NN	B-NP	O
PNA	PNA	NN	I-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
vasc	vasc	NN	B-NP	O
congestion	congestion	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
+	+	SYM	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
spine	spine	NN	I-NP	O
sign	sign	NN	I-NP	O
;	;	:	O	O
TTE	TTE	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
10/21/05	10/21/05	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
AS	AS	JJ	B-NP	O
AVA	AVA	NN	I-NP	O
0.74	0.74	CD	I-NP	O
cm2	cm2	NN	I-NP	O
,	,	,	O	O
LVEF	LVEF	NN	B-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
mod	mod	NN	B-NP	O
TR	TR	NN	I-NP	O
;	;	:	O	O
Consults	Consult	NNS	B-NP	O
:	:	:	O	O
2/20	2/20	CD	B-NP	O
Put	Put	NN	I-NP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
Resp	Resp	NN	B-NP	O
Therapy	Therapy	NN	I-NP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
Nocturnal	Nocturnal	NNP	B-NP	O
02	02	CD	B-NP	O
sats	sat	NNS	I-NP	O
Problem	Problem	NNP	B-NP	O
List	List	NNP	I-NP	O
:	:	:	O	O
CV-I	CV-I	NN	B-NP	O
:	:	:	O	O
?	?	.	O	O

h/o	h/o	NN	B-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
by	by	IN	B-PP	O
previous	previous	JJ	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
;	;	:	O	O
nNZ	nNZ	NN	B-NP	B-protein
's	's	POS	B-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
x1	x1	NN	I-NP	I-protein
;	;	:	O	O
no	no	DT	B-NP	O
ASA	ASA	NN	I-NP	O
given	give	VBN	B-PP	O
h/o	h/o	NN	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
;	;	:	O	O
cont	cont	JJ	B-NP	O
statin	statin	NN	I-NP	O
;	;	:	O	O
CV-P	CV-P	NN	B-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	B-protein
likely	likely	RB	B-ADJP	O
from	from	IN	B-PP	O
bad	bad	JJ	B-NP	B-protein
AS	AS	NN	I-NP	I-protein
;	;	:	O	O
try	try	NN	B-NP	O
to	to	TO	B-VP	O
diurese	diurese	VB	I-VP	O
with	with	IN	B-PP	O
iv	iv	JJ	B-NP	O
torsemide	torsemide	NN	I-NP	O
100	100	CD	I-NP	O
bid	bid	NN	I-NP	O
and	and	CC	I-NP	O
zaroxylyn	zaroxylyn	NN	I-NP	O
5	5	CD	I-NP	O
bid	bid	NN	I-NP	O
;	;	:	O	O
goal	goal	NN	B-NP	O
-2	-2	CD	I-NP	O
L	L	NN	I-NP	O
/	/	SYM	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
BNP	BNP	NN	B-NP	B-protein
or	or	CC	I-NP	O
dobutamine	dobutamine	NN	I-NP	O
drip	drip	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
on	on	IN	B-PP	O
prior	prior	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
;	;	:	O	O
11/18	11/18	CD	B-NP	O
BACK	BACK	NN	I-NP	O
ON	ON	NNP	I-NP	O
HOME	HOME	NNP	I-NP	O
REGIMEN	REGIMEN	NNP	I-NP	O
B/C	B/C	NNP	I-NP	O
FEEL	FEEL	NNP	I-NP	O
overdiuresed	overdiurese	VBD	B-VP	O
:	:	:	O	O
torsemide	torsemide	NN	B-NP	O
150	150	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Zaroxylyn	Zaroxylyn	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Aldactone	Aldactone	NN	B-NP	O
25	25	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
CV-R	CV-R	NN	I-NP	O
:	:	:	O	O
known	know	VBN	B-VP	O
chronic	chronic	JJ	B-NP	O
afib	afib	NN	I-NP	O
;	;	:	O	O
not	not	RB	B-NP	O
coumadin	coumadin	NN	I-NP	O
candidate	candidate	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
meds	med	NNS	I-NP	O
needed	need	VBD	B-VP	O
yet	yet	RB	B-ADVP	O
;	;	:	O	O
PULM	PULM	NN	B-NP	O
:	:	:	O	O
OSA	OSA	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
does	do	VBZ	B-VP	O
n't	n't	RB	I-VP	O
tolerate	tolerate	VB	I-VP	O
CPAP	CPAP	NN	B-NP	B-protein
;	;	:	O	O
Afebrile	Afebrile	NNP	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
WBC	WBC	NN	I-NP	B-protein
,	,	,	O	O
CXR	CXR	NN	B-NP	B-protein
pending	pende	VBG	B-PP	O
RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
known	know	VBN	B-NP	O
CKD	CKD	NN	I-NP	B-protein
;	;	:	O	O
no	no	DT	B-NP	O
ACE	ACE	NN	I-NP	O
or	or	CC	I-NP	O
ARB	ARB	NN	I-NP	B-protein
as	as	IN	B-PP	O
o/p	o/p	NN	B-NP	O
;	;	:	O	O
baseline	baseline	NN	B-NP	O
cr	cr	NN	I-NP	O
1.5-2	1.5-2	CD	B-NP	O
.3	.3	NN	I-NP	O
;	;	:	O	O
ENDO	ENDO	NN	B-NP	O
:	:	:	O	O
known	know	VBN	B-NP	O
DM	DM	NN	I-NP	O
cover	cover	NN	I-NP	O
with	with	IN	B-PP	O
nph	nph	NN	B-NP	O
25	25	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
15	15	CD	I-NP	O
qac	qac	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
RISS	RISS	NN	B-NP	B-protein
;	;	:	O	O
known	know	VBN	B-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
,	,	,	O	O
chech	chech	NN	B-NP	O
tsh	tsh	NN	I-NP	O
,	,	,	O	O
cont	cont	NN	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
levoxyl	levoxyl	NN	I-NP	O
;	;	:	O	O
GI	GI	NN	B-NP	O
:	:	:	O	O
h/o	h/o	NN	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
;	;	:	O	O
nexium	nexium	NN	B-NP	O
qd	qd	NN	I-NP	O
;	;	:	O	O
ID	ID	NN	B-NP	O
:	:	:	O	O
Has	Has	NNP	B-NP	O
UTI	UTI	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
most	most	RBS	B-NP	O
likely	likely	JJ	I-NP	O
E-Coli	E-Coli	NNP	I-NP	O
-	-	:	O	O
on	on	IN	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
-	-	HYPH	I-NP	O
sensitivities	sensitivity	NNS	I-NP	O
pending	pende	VBG	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
FEN	FEN	NNP	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
,	,	,	O	O
K	K	NN	B-NP	O
scales	scale	NNS	I-NP	O
;	;	:	O	O
FC	FC	NN	B-NP	O
;	;	:	O	O
ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CALL	CALL	NNP	I-NP	O
DR.	DR.	NNP	I-NP	O
BLOODOUGH	BLOODOUGH	NNP	I-NP	O
,	,	,	O	O
AND	AND	NNP	B-NP	O
DR.	DR.	NNP	I-NP	O
PAGNI	PAGNI	NNP	I-NP	O
's	's	POS	B-NP	O
OFFICES	OFFICES	NNP	I-NP	O
IN	IN	NN	I-NP	O
AM	AM	VBP	B-VP	O
TO	TO	TO	B-PP	O
SCHEDULE	SCHEDULE	NN	B-NP	O
APPTS	APPTS	NN	I-NP	O
FOR	FOR	NN	I-NP	O
NEXT	NEXT	NN	I-NP	O
WEEK	WEEK	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	HYPH	O	O
You	You	PRP	B-NP	B-protein
are	be	VBP	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
diuretic	diuretic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	I-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
that	that	IN	B-NP	O
you	you	PRP	B-NP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
on	on	IN	B-PP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Limit	Limit	NNP	I-NP	O
fluid	fluid	NN	I-NP	O
intake	intake	NN	I-NP	O
to	to	TO	B-PP	O
2L	2L	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
CABAN	CABAN	NN	B-NP	B-protein
,	,	,	O	O
ALFONSO	ALFONSO	NNP	B-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.PH	M.PH	NNP	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
MY19	MY19	NN	B-NP	B-protein
-RRB-	-RRB-	SYM	O	O
1/1/05	1/1/05	CD	B-NP	O
@	@	SYM	I-NP	O
08	08	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

